| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6951cc3d4a12e48bbc7096e358735ddf |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4706
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1611
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4706 |
| filingDate |
2006-05-22^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_135c75cadf41f7a961961de483aeff5d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e20ded79df07d0a4704e27045a5f759f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3490009673840e2039e9eea7636c0587
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd9de0bc2f4b3f7d2beab882d502c10a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4cd7ea6c286d89a0f839bc23a82afa2b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_884189a84aec3fca3dadcc64281bd842 |
| publicationDate |
2009-05-07^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2009118328-A1 |
| titleOfInvention |
Pharmaceutical Compositions Of Cholesteryl Ester Transfer Protein Inhibitors And Hmg-Coa Reductase |
| abstract |
A solid amorphous dispersion comprises a cholesteryl ester transfer protein (CETP) inhibitor, an inhibitor of 3-hydroxy-3-methylglutaryl-conenzyme A reductase (HMG-CoA reductase inhibitor), and a concentration enhancing polymer. At least a major portion of the CETP inhibitor in the dispersion is amorphous. The solid amorphous dispersion provides concentration-enhancement of the CETP inhibitor when administered to an aqueous use environment. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006178514-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9199967-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9000007-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9040558-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9765030-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9782407-B2 |
| priorityDate |
2005-05-31^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |